Neuroichthyosis With a De Novo Variant c.494C>T in ELOVL1 and Severe Pruritus Relieved by Dupilumab
Pediatric Dermatology · 2025-07 · 42 (4) · 844-848
DOI: 10.1111/pde.15904 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Dermatology, online erschienen am 11.03.2025. Verfasst von Danielle Marcoux und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Pruritus, Antibodies, Monoclonal, Humanized, Fatty Acid Elongases, Acetyltransferases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
We report a patient with neuroichthyosis with an ELOVL1 variant associated with severe pruritus who responded well to dupilumab therapy. Our case is the third known patient reported with this de novo heterozygous dominant variant. The feature of severe progressive pruritus greatly impairing quality of life is unique among these reports. After multiple treatment failures, he responded well clinically and subjectively to the monoclonal antibody dupilumab.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Montreal, Quebec, Canada.
- Sainte-Justine University Hospital Center, Montreal, Quebec, Canada.
- Divison of Pediatric Dermatology, Montreal, Quebec, Canada.
- Department of Pathology and Cellular Biology, Montreal, Quebec, Canada.
- Departments of Neurosciences and Pediatrics, Montreal, Quebec, Canada.
- Department of Ophthalmology, Montreal, Quebec, Canada.
ORCID-Profile: Sophie-Anne Savard
Zitieren
APA
Marcoux, D., Savard, S. A., Kokta, V., Rossignol, E., & Ospina, L. H. (2025). Neuroichthyosis With a De Novo Variant c.494C>T in ELOVL1 and Severe Pruritus Relieved by Dupilumab. Pediatric Dermatology, 42(4), 844-848. https://doi.org/10.1111/pde.15904
Vancouver
Marcoux D, Savard SA, Kokta V, Rossignol E, Ospina LH. Neuroichthyosis With a De Novo Variant c.494C>T in ELOVL1 and Severe Pruritus Relieved by Dupilumab. Pediatric Dermatology. 2025;42(4):844-848. doi:10.1111/pde.15904
BibTeX
@article{Marcoux2025,
author = {Marcoux, Danielle and Savard, Sophie-Anne and Kokta, Victor and Rossignol, Elsa and Ospina, Luis H},
title = {Neuroichthyosis With a De Novo Variant c.494C>T in ELOVL1 and Severe Pruritus Relieved by Dupilumab},
journal = {Pediatric Dermatology},
year = {2025},
volume = {42},
number = {4},
pages = {844--848},
doi = {10.1111/pde.15904}
}
EUVIMED